Minami K, Ueda N, Ishimoto K, Kurisu R, Takamoto M, Ikeda H, Tsujiuchi T.
Roles of endothelial cells in the regulation of cell motility via lysophosphatidic
acid receptor-2 (LPA2) and LPA3 in osteosarcoma cells. Exp Mol Pathol.
118 (2021) 104596.
【2020年】
Minami K, Ueda N, Ishimoto K, Kurisu R, Takamoto M, Ikeda H, Tsujiuchi T.
Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA2) signaling enhances cancer cell survival to cisplatin. Biochem Biophys Res Commun. 532 (2020) 427-432.
Ueda N, Minami K, Ishimoto K, Tsujiuchi T.
Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells. Cell Signal. 69 (2020) 109551.
Minami K, Ueda N, Ishimoto K, Tsujiuchi T.
LPA5-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells. Exp Cell Res. 388 (2020) 111813.
Ishimoto K, Minami A, Minami K, Ueda N, Tsujiuchi T.
Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells. J Recept Signal Transduct Res. 16 (2020) 1-6.
Minami K, Ueda N, Ishimoto K, Tsujiuchi T.
Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs. Mol Cell Biochem. 469 (2020) 89-95.
Minami K, Ueda N, Ishimoto K, Tsujiuchi T.
Regulation of cell survival through free fatty acid receptor 1 (FFA1) and FFA4 induced by endothelial cells in osteosarcoma cells. J Recept Signal Transduct Res. 40 (2020) 181-186.